Literature DB >> 32284222

The active role of a blood center in outpacing the transfusion transmission of COVID-19.

Manish Raturi1, Anuradha Kusum2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32284222      PMCID: PMC7151365          DOI: 10.1016/j.tracli.2020.03.004

Source DB:  PubMed          Journal:  Transfus Clin Biol        ISSN: 1246-7820            Impact factor:   1.406


× No keyword cloud information.
Sir, Since a group of unknown pneumonia patients were found in December 2019 in Wuhan, China, a novel coronavirus (nCoV), suddenly came into our sight [1]. The virus was subsequently renamed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), and the disease it causes was named Coronavirus Disease 2019 (COVID-19). Having spread to the entire globe with deaths accounting in thousands, on January 31st 2020, WHO announced the outbreak of COVID-19 as the Public Health Emergency of International Concern [PHIEC] [2]. Furthermore, in the year 2002–2003, more than 8000 patients suffered from SARS due to a β coronavirus, with 774 deaths reported. Since September 2012, there were 2494 laboratory-confirmed cases of infection with Middle East Respiratory Syndrome Coronavirus (MERS-CoV), with 858 deaths reported [3], [4]. Although WHO noted in 2003 that no cases of SARS-CoV have been reported due to transfusion of blood products, there is still a theoretical risk of transmission of SARS-CoV-2 through blood transfusion. Additionally, with more asymptomatic carriers of the COVID-19, blood safety is worthy of consideration. The current recommendations are based largely on the new guidelines released by AABB, and a precautionary approach includes vigilant blood donor surveillance which is the desirable need of the hour [5]. Ours is a tertiary care blood centre catering to a 1200-bedded academic hospital in the Dehradun district of Uttarakhand, North India. In the wake of this COVID-19 outbreak, we took the following measures and included them in the otherwise routine blood donor screening protocol at our centre: a standard mini-physical included taking body temperature before blood donation in those who present with high pulse rate (> 100bpm on two consecutive checks at a definitive interval of 5 minutes) or those giving a history of fever in past 7 days; additional questions were added in the donor-screening program intending for the donors to self-screen before coming in to donate. This encouraged them to refrain from donation if they had: fever or other symptoms of COVID-19 (cough, shortness of breath, or difficulty breathing), having close contact with someone diagnosed with or suspected of having COVID-19 in the last 14 days, traveled outside the country [Deferred for 28 days starting from the date of return] and or have been diagnosed with or suspected of having COVID-19 until 28 days after the illness has been resolved, however, if they felt healthy and well and met the general eligibility conditions, we welcomed their donation to help ensure stable bloodstock amid the nCoV outbreak; follow-up of all the blood donors by telephonically calling them and asking the donors and their family about their current physical condition within the next 3 days after their last donation; another interesting initiative in order to protect our staff was to encourage them for home quarantine in case they were feeling ill. Additionally, our staffs are trained in universal precautions to help prevent the risk of spreading germs, including regular cleaning of public surfaces of contamination potential. Additionally, we displayed the donor information and education material at our centre that addressed the following questions and answers [Q & A]: Q1: Can I catch COVID-19 by blood donation? A1: Donating blood is safe. We always use new, sterile needles that are discarded after a single-use. Q2: Do you test blood before it goes to the recipients? A2: All donated blood, even donations from repeat donors, is tested for blood type, irregular erythrocyte antibodies, hepatitis B & C, HIV- I & II, syphilis, and malaria according to our national guidelines [6]. Q3: Can I donate blood to find out if I have COVID-19? A3: Blood centres are not authorized to test for COVID-19. Q4: Can somebody catch COVID-19 from a blood transfusion? A4: There is no such evidence yet that proves the transfusion transmissibility of the coronaviruses. Furthermore, pre-donation screening procedures are designed to prevent donations from people with flu-like symptoms or any such respiratory illness. Q5: Why is it important to donate now? A5: Blood is a critical component of emergency preparedness. It is perishable and the supply must be constantly replenished. It's important for eligible blood and platelet donors to give today so that we can have strong bloodstock whenever needed. Q6: Will we run out of bloodstock due to COVID-19 outbreak? A6: In the wake of this outbreak, nCoV outbreak, all the voluntary blood donation drives are getting cancelled as a curtailment strategy from mass gatherings; therefore, our community's blood supply is certainly bound to drop. We need to build up our reserves today so that we have enough blood available to withstand any transient shortage in future. Q7: What can I do to protect myself from COVID-19? A7: Standard practices for cold and flu-like illness are the best way to keep you and your community healthy. This includes home quarantine if feeling sick, meticulous hand hygiene either with disinfectants and or with soap and water, adherence to proper cough etiquette and avoiding touching your eyes, nose, or face after touching public surfaces. With these measures in place, we wish to combat the novel variant of CoV at our blood centre. Knowledge of the COVID-19 is evolving every day. However, routine blood donor screening measures that are already in place should be able to prevent individuals with active respiratory infections from donating blood.

Research involving human participants and/or animals

Human participant.

Informed consent

As per our hospital policy an informed consent is obtained from all the individual blood donors prior to donation at our facility.

Ethical approval

All procedures performed in studies involving human participants will be in accordance with the ethical standards of the institutional ethics committee.

Financial support and sponsorship

Nil.

Disclosure of interest

The authors declare that they have no competing interest.
  1 in total

1.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

  1 in total
  7 in total

1.  Endorsing a permanent lifting of the ban on men who have sex with men and transgender from donating their whole blood.

Authors:  Manish Raturi; Kunal Das; Yashaswi Dhiman
Journal:  Indian J Sex Transm Dis AIDS       Date:  2022-06-07

2.  Clinical practice guidance for hepatology and liver transplant providers during the COVID-19 pandemic: APASL expert panel consensus recommendations.

Authors:  George Lau; Manoj Sharma
Journal:  Hepatol Int       Date:  2020-05-23       Impact factor: 6.047

Review 3.  Blood Banking and Transfusion Medicine Challenges During the COVID-19 Pandemic.

Authors:  Andy Ngo; Debra Masel; Christine Cahill; Neil Blumberg; Majed A Refaai
Journal:  Clin Lab Med       Date:  2020-08-08       Impact factor: 1.935

Review 4.  Current Perspectives of convalescent plasma therapy in COVID-19.

Authors:  Kamal Kant Sahu; Ajay Kumar Mishra; Manish Raturi; Amos Lal
Journal:  Acta Biomed       Date:  2020-11-10

5.  Reviewing the Ethical Concerns of the Convalescent Plasma Therapy in COVID-19.

Authors:  Manish Raturi; Mansi Kala; Kunal Das; Anuradha Kusum
Journal:  J Lab Physicians       Date:  2021-04-24

6.  [Management of patients with hematological malignancies in outbreak areas of COVID-19 epidemic: our experience at Wuhan Tongji Hospital].

Authors:  Y Xiao; Y Cao; L Huang; M Zheng; F K Meng; W Huang; C R Li; M Huang; Y C Zhang; D H Zhang; J N Deng; L Meng; H Y Sun; Y Tang; D J Li; Y Wan; L Xu; J F Zhou
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-07-14

7.  Preoperative anemia management in the coronavirus disease (COVID-19) era.

Authors:  Seth I Perelman; Aryeh Shander; Christian Mabry; Victor A Ferraris
Journal:  JTCVS Open       Date:  2021-01-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.